Impact of corrections on connectivity. by Jan Willem Koten (17743224)

Subjects:

S1 Data - by Jan Willem Koten (17743224)

Subjects:

Connectivity statistics. by Jan Willem Koten (17743224)

Subjects:

Hypothetical versus random connectomes. by Jan Willem Koten (17743224)

Subjects:

Thresholds and group reproducibility. by Jan Willem Koten (17743224)

Subjects:

Reproducibility of response time and brain measures. by Jan Willem Koten (17743224)

Subjects:

Results of significance for regression factors. by Junxia Zhou (14381598)

Subjects:

Lipid layer thickness distribution in the inferior half of cornea (nm). by Yongwoo Lee (2265172)

Subjects:

Flowchart of overall study protocol. by Yongwoo Lee (2265172)

Subjects:

Changes in symptom scores and signs of dry eye disease and meibomian gland dysfunction after treatment with intensive pulse light and meibomian gland expression (n =  218). by Yongwoo Lee (2265172)

Subjects:

Change in the vertical distribution of the lipid layer thickness after intensive pulse light treatment (IPL; nm) combined with meibomian gland expression (MGX). by Yongwoo Lee (2265172)

Subjects:

Patient demographics. by Yongwoo Lee (2265172)

Subjects:

NgR1 KO mice exhibited an increase in excitatory synapses and a decrease in inhibitory synapses, indicating an imbalance of synaptic transmission. by Jinwei Zhang (462455)

“…The inhibitory synaptic density of NgR1 mice showed a significant decrease when compared to WT mice (***P <  0.001). …”

Statistically significant linear increase in use of psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics, gabapentinoids during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and simple steatosis (SS) groups, and adjusted p-values. by Laia Bertran (3685147)

Impact of 5′ nucleotidase disruption on <i>M</i>. <i>bovis</i> growth phenotype in axenic conditions. by Aga E. Gelgie (17661720)

Subjects:

The cleft width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

The dental arch length at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

The alveolar width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

The dental arch width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects: